Drug
ZL 1503
ZL 1503: highest development phase Phase 1, developed by Zai Lab. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-1503 NCT07658482 | Phase 1 | Healthy Volunteers |
| ZL-1503 NCT07235384 | Phase 1 | Atopic Dermatitis (AD) |
Latest
No recent events.
Follow ZL 1503 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.